Literature DB >> 8093605

Glucose transport in human skeletal muscle. The in vivo response to insulin.

R C Bonadonna1, M P Saccomani, L Seely, K S Zych, E Ferrannini, C Cobelli, R A DeFronzo.   

Abstract

Transmembrane glucose transport plays a key role in determining insulin sensitivity. We have measured in vivo WBGU, FGU, and K(in) and K(out) of 3-O-methyl-D-glucose in forearm skeletal muscle by combining the euglycemic clamp technique, the forearm-balance technique, and a novel dual-tracer (1-[3H]-L-glucose and 3-O-[14C]-methyl-D-glucose) technique for measuring in vivo transmembrane transport. Twenty-seven healthy, lean subjects were studied. During saline infusion, insulin concentration, FGU (n = 6), K(in), and K(out) (n = 4) were similar to baseline. During SRIF-induced hypoinsulinemia (insulin < 15 pM, n = 4) WBGU was close to 0, and FGU, K(in), and K(out) were unchanged from basal (insulin = 48 pM) values. During insulin clamps at plasma insulin levels of approximately 180 (n = 4), approximately 420 (n = 5), approximately 3000 (n = 4), and approximately 9500 pM (n = 4), WBGU was 14.2 +/- 1.3, 34.2 +/- 4.1 (P < 0.05 vs. previous step), 55.8 +/- 1.8 (P < 0.05 vs. previous step), and 56.1 +/- 6.3 mumol.min-1.kg-1 of body weight (NS vs. previous step), respectively. Graded hyperinsulinemia concomitantly increased FGU from a basal value of 4.7 +/- 0.5 mumol.min-1.kg-1 up to 10.9 +/- 2.3 (P < 0.05 vs. basal value), 26.6 +/- 4.5 (P < 0.05 vs. previous step), 54.8 +/- 4.3 (P < 0.05 vs. previous step), and 61.1 +/- 10.8 mumol.min-1.kg-1 of forearm tissues (NS vs. previous step), respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093605     DOI: 10.2337/diab.42.1.191

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

1.  Dynamic PET imaging reveals heterogeneity of skeletal muscle insulin resistance.

Authors:  Jason M Ng; Alessandra Bertoldo; Davneet S Minhas; Nicole L Helbling; Paul M Coen; Julie C Price; Claudio Cobelli; David E Kelley; Bret H Goodpaster
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

2.  Assessment of insulin resistance in fructose-fed rats with 125I-6-deoxy-6-iodo-D-glucose, a new tracer of glucose transport.

Authors:  Pascale Perret; Lotfi Slimani; Arnaud Briat; Danièle Villemain; Serge Halimi; Jacques Demongeot; Daniel Fagret; Catherine Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-15       Impact factor: 9.236

Review 3.  Metabolic and therapeutic lessons from genetic manipulation of GLUT4.

Authors:  M J Charron; E B Katz
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

4.  Development of an in vitro reconstitution assay for glucose transporter 4 translocation.

Authors:  G Inoue; B Cheatham; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.

Authors:  G Paternostro; P G Camici; A A Lammerstma; N Marinho; R R Baliga; J S Kooner; G K Radda; E Ferrannini
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

6.  Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.

Authors:  H Laine; H Yki-Jarvinen; O Kirvela; T Tolvanen; M Raitakari; O Solin; M Haaparanta; J Knuuti; P Nuutila
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

7.  Control of muscle glucose uptake: test of the rate-limiting step paradigm in conscious, unrestrained mice.

Authors:  Patrick T Fueger; Jane Shearer; Deanna P Bracy; Kelly A Posey; R Richard Pencek; Owen P McGuinness; David H Wasserman
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

8.  Low-dose Iloprost infusion improves insulin action and non-oxidative glucose metabolism in hypertensive patients.

Authors:  G Paolisso; A Gambardella; F Saccomanno; G Varricchio; A D'Amore; M Varricchio
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

9.  Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.

Authors:  R C Bonadonna; S Del Prato; M P Saccomani; E Bonora; G Gulli; E Ferrannini; D Bier; C Cobelli; R A DeFronzo
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  Glucose levels at the site of subcutaneous insulin administration and their relationship to plasma levels.

Authors:  Stefan Lindpointner; Stefan Korsatko; Gerd Köhler; Hans Köhler; Roland Schaller; Lukas Schaupp; Martin Ellmerer; Thomas R Pieber; Werner Regittnig
Journal:  Diabetes Care       Date:  2010-01-22       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.